1. Home
  2. TNGX vs HDSN Comparison

TNGX vs HDSN Comparison

Compare TNGX & HDSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • HDSN
  • Stock Information
  • Founded
  • TNGX 2014
  • HDSN 1991
  • Country
  • TNGX United States
  • HDSN United States
  • Employees
  • TNGX N/A
  • HDSN N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • HDSN Industrial Specialties
  • Sector
  • TNGX Health Care
  • HDSN Consumer Discretionary
  • Exchange
  • TNGX Nasdaq
  • HDSN Nasdaq
  • Market Cap
  • TNGX 351.2M
  • HDSN 291.8M
  • IPO Year
  • TNGX N/A
  • HDSN 1994
  • Fundamental
  • Price
  • TNGX $5.16
  • HDSN $7.74
  • Analyst Decision
  • TNGX Strong Buy
  • HDSN Buy
  • Analyst Count
  • TNGX 6
  • HDSN 4
  • Target Price
  • TNGX $12.20
  • HDSN $7.44
  • AVG Volume (30 Days)
  • TNGX 3.9M
  • HDSN 386.0K
  • Earning Date
  • TNGX 08-06-2025
  • HDSN 08-05-2025
  • Dividend Yield
  • TNGX N/A
  • HDSN N/A
  • EPS Growth
  • TNGX N/A
  • HDSN N/A
  • EPS
  • TNGX N/A
  • HDSN 0.38
  • Revenue
  • TNGX $40,990,000.00
  • HDSN $227,211,000.00
  • Revenue This Year
  • TNGX N/A
  • HDSN N/A
  • Revenue Next Year
  • TNGX N/A
  • HDSN $9.83
  • P/E Ratio
  • TNGX N/A
  • HDSN $20.36
  • Revenue Growth
  • TNGX 10.09
  • HDSN N/A
  • 52 Week Low
  • TNGX $1.03
  • HDSN $5.11
  • 52 Week High
  • TNGX $12.02
  • HDSN $9.28
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 79.99
  • HDSN 60.59
  • Support Level
  • TNGX $4.40
  • HDSN $7.62
  • Resistance Level
  • TNGX $5.37
  • HDSN $8.04
  • Average True Range (ATR)
  • TNGX 0.65
  • HDSN 0.23
  • MACD
  • TNGX 0.10
  • HDSN 0.03
  • Stochastic Oscillator
  • TNGX 93.68
  • HDSN 71.43

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

About HDSN Hudson Technologies Inc.

Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.

Share on Social Networks: